MedPath

Triamcinolone-Moxifloxacin PF

Approved
Approval ID

62fce8cd-0956-2830-e053-2991aa0a041c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 10, 2020

Manufacturers
FDA

Imprimis NJOF, LLC

DUNS: 080431967

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Triamcinolone-Moxifloxacin PF

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71384-510
Product Classification
G
Generic Name
Triamcinolone-Moxifloxacin PF
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 10, 2020
FDA Product Classification

INGREDIENTS (2)

TRIAMCINOLONE ACETONIDEActive
Quantity: 15 mg in 1 mL
Code: F446C597KA
Classification: ACTIB
MOXIFLOXACIN HYDROCHLORIDE MONOHYDRATEActive
Quantity: 1 mg in 1 mL
Code: B8956S8609
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Triamcinolone-Moxifloxacin PF - FDA Drug Approval Details